back to Meetings page
Participants
Agenda
  • IMMPACT-III
  • November 21-22, 2003
  • Four Seasons Hotel
  • Washington, DC

  • Co-chairs:
  • Dennis C. Turk, PhD (University of Washington)
  • Robert H. Dworkin, PhD (University of Rochester)
  • Academia Participants
  • J. Hampton Atkinson, MD (University of California, San Diego)
  • Charles S. Cleeland, PhD (MD Anderson Cancer Center)
  • John T. Farrar, MD (University of Pennsylvania)
  • Richard Gershon, PhD (Northwestern University)
  • Jennifer Haythornthwaite, PhD (Johns Hopkins University)
  • Alejandro R. Jadad, MD, DPhil (University of Toronto)
  • Mark P. Jensen, PhD (University of Washington)
  • Robert D. Kerns, PhD (Yale University)
  • Michael McDermott, PhD (University of Rochester)
  • Patrick McGrath, PhD (Dalhousie University)
  • Dwight E. Moulin, MD (London Regional Cancer Centre, Ontario)
  • Turo Nurmikko, MD, PhD (Pain Research Institute, Liverpool)
  • Srinivasa Raja, MD (Johns Hopkins University)
  • James P. Robinson, MD, PhD (University of Washington)
  • Gerold Stucki, MD (University of Munich)
  • Mark S. Wallace, MD (University of California, San Diego)
  • Amanda C. Williams, PhD (St. Thomas Hospital, London)
  • Kathleen W. Wyrwich, PhD (Saint Louis University)
  • Government Participants
  • Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
  • Raymond Dionne, DDS, PhD (US National Institute of Health)
  • Sharon Hertz, MD (US Food and Drug Administration)
  • Mitchell B. Max, MD (National Institute of Health)
  • Bob A. Rappaport, MD (US Food and Drug Administration)
  • Jane Scott, PhD (US Food and Drug Administration)
  • Lee Simon, MD (US Food and Drug Administration)
  • Jane Tollett, RN, PhD (US Department of Veterans Affairs)
  • James Witter, MD, PhD (US Food and Drug Administration)
  • Patient Representative
  • Penney Cowan (American Chronic Pain Asssociation)
  • Industry Participants
  • Julie Chandler, PhD (Merck & Company)
  • Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
  • David Kellstein, PhD (Novartis Pharmaceuticals)
  • Donald C. Manning, MD, PhD (Celgene Corporation)
  • Susan Martin, MSPH (Pfizer)
  • Steven Quessy, PhD (GlaxoSmithKline)
  • Christine Rauschkolb, MD, PhD (Schwarz Biosciences GmbH)
  • Margaret Rothman, PhD (Johnson & Johnson)
  • Michael A. Royal, MD, JD (Alpharma)
  • Joseph W. Stauffer, DO (Abbott Laboratories)
  • Thorsten von Stein, MD, PhD (NeurogesX, Inc.)
  • Emmeline R. Watkins, PhD (AstraZeneca Pharmaceuticals)
  • Joachim Wernicke, MD, PhD (Eli Lilly & Co.)
  • Richard E. White, PhD (Endo Pharmaceuticals)